Merck & Co.’s new antiviral pill – once touted as a potential game changer for treating COVID-19 – is the last choice among four available options for at-risk patients given its relatively low efficacy and potential safety issues, U.S. doctors, healthcare systems and pharmacies told Reuters.
The MIT Center for Collective Intelligence and MilliporeSigma brought together the thought-power of gurus in science, healthcare, public policy and other sectors to answer the question: how do we apply what we have learned from the COVID-19 pandemic for the future?
India postponed exams for trainee doctors and nurses on May 3, freeing them up to fight the world’s biggest surge in coronavirus infections, as the health system crumbles under the weight of new cases and hospitals run out of beds and oxygen.
U.S. hospitals have been slow to embrace Covid-19 antibody drugs from Eli Lilly and Co. and Regeneron Pharmaceuticals Inc. that were authorized to reduce the risk of hospitalization, U.S. officials said.
The Covid-19 pandemic has forced healthcare systems and physician’s practices to innovate and try new approaches to care delivery, resulting in the explosive growth of telehealth services. But a comprehensive digital solution can involve much more than the video encounters people typically associate with virtual care.
Health Canada on Dec. 9 approved the Covid-19 vaccine from Pfizer Inc. and BioNTech SE, clearing the way for shots to be delivered and administered across the country.
Beckman Coulter will be using a grant from BARDA (the Biomedical Advanced Research and Development Authority, a division of the Dept. of Health and Human Services) to validate the ability of the company’s Monocyte Distribution Width (MDW) hematology biomarker to aid in the rapid detection of a rare but serious complication of Covid-19 affecting children.
Bryen Pittner, a Strategic Planner for FCB Health New York, discusses how healthcare brands can reach patients meaningfully at three key touchpoints in a simple transactional journey.
According to a new study by Worldwide Partners, the effect that Covid-19 is having on digital health adoption is set to be transformative. The survey that was conducted shows technology is playing a crucial and growing role in mitigating the healthcare crisis, especially via telehealth.
W2O, a leading independent provider of analytics-driven, technology-enabled marketing and communications solutions to the healthcare sector, announced the acquisition of Discern Health.